Mechanistic Safety and ADME Sciences, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.
Mechanistic Safety and ADME Sciences, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom
Drug Metab Dispos. 2018 Nov;46(11):1647-1657. doi: 10.1124/dmd.118.082750. Epub 2018 Aug 22.
Transmembrane flux of a drug within a tissue or organ frequently involves a complex system of transporters from multiple families that have redundant and overlapping specificities. Current in vitro systems poorly represent physiology, with reduced expression and activity of drug transporter proteins; therefore, novel models that recapitulate the complexity and interplay among various transporters are needed. The development of microphysiological systems that bring simulated physiologic conditions to in vitro cell culture models has enormous potential to better reproduce the morphology and transport activity across several organ models, especially in tissues such as the liver, kidney, intestine, or the blood-brain barrier, in which drug transporters play a key role. The prospect of improving the in vitro function of organ models highly prolific in drug transporters holds the promise of implementing novel tools to study these mechanisms with far more representative biology than before. In this short review, we exemplify recent developments in the characterization of perfused microphysiological systems involving the activity of drug transporters. Furthermore, we analyze the challenges and opportunities for the implementation of such systems in the study of transporter-mediated drug disposition and the generation of clinically relevant physiology-based in silico models incorporating relevant drug transport activity.
药物在组织或器官内的跨膜通量通常涉及来自多个家族的多种转运体的复杂系统,这些转运体具有冗余和重叠的特异性。当前的体外系统不能很好地反映生理学,药物转运蛋白的表达和活性降低;因此,需要新型模型来再现各种转运体之间的复杂性和相互作用。将模拟生理条件的微生理系统应用于体外细胞培养模型的发展具有巨大的潜力,可以更好地复制多个器官模型的形态和转运活性,特别是在肝脏、肾脏、肠道或血脑屏障等组织中,药物转运体在其中发挥着关键作用。改善富含药物转运体的器官模型的体外功能有望实现新的工具,以前所未有的更具代表性的生物学来研究这些机制。在这篇简短的综述中,我们举例说明了最近在涉及药物转运体活性的灌注微生理系统的表征方面的进展。此外,我们分析了在研究转运体介导的药物处置和生成包含相关药物转运活性的基于临床相关生理学的计算模型时实施此类系统的挑战和机遇。